Publicacións en colaboración con investigadores/as de Universidad Complutense de Madrid (289)

2024

  1. A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies

    OncoImmunology, Vol. 13, Núm. 1

  2. Association between Beverage Consumption and Environmental Sustainability in an Adult Population with Metabolic Syndrome

    Nutrients, Vol. 16, Núm. 5

  3. Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit

    Journal of Clinical Medicine, Vol. 13, Núm. 4

  4. Effect of functionalized titanium particles with dexamethasone-loaded nanospheres on macrophage polarization and activity

    Dental Materials, Vol. 40, Núm. 1, pp. 66-79

  5. Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis

    Menopause (New York, N.Y.), Vol. 31, Núm. 3, pp. 234-242

  6. How severity of intimate partner violence is perceived and related to attitudinal variables? A systematic review and meta-analysis

    Aggression and Violent Behavior, Vol. 76

  7. Miettinen and Nurminen score statistics revisited

    Journal of Biopharmaceutical Statistics

  8. Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer

    Journal of Clinical Oncology, Vol. 42, Núm. 9, pp. 994-1000

  9. Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study

    European Journal of Cancer, Vol. 196

  10. Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives

    Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651

  11. Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain

    Pediatric Infectious Disease Journal, Vol. 43, Núm. 1, pp. 40-48

  12. Trastuzumab deruxtecan in breast cancer

    Critical Reviews in Oncology/Hematology, Vol. 198